Singapore markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4200+0.0700 (+5.19%)
At close: 04:00PM EDT
1.4400 +0.02 (+1.41%)
Pre-market: 09:09AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
16,666
15,083
9,210
6,608
Selling general and administrative
13,830
12,608
11,311
7,999
Total operating expenses
30,496
27,691
20,521
14,607
Operating income or loss
-30,496
-27,691
-20,521
-14,607
Total other income/expenses net
-3,112
-146
-91
-3,221
Income before tax
-29,831
-26,960
-20,606
-17,828
Income tax expense
0
0
0
0
Income from continuing operations
-29,831
-26,960
-20,606
-17,828
Net income
-29,831
-26,960
-20,606
-17,828
Net income available to common shareholders
-29,831
-26,960
-20,606
-22,331
Basic EPS
-0.24
-0.21
-0.18
-1.97
Diluted EPS
-0.24
-0.21
-0.18
-1.97
Basic average shares
126,414
126,624
116,950
11,309
Diluted average shares
126,414
126,624
116,950
11,309